News

Recent news about Panacea Capital and select portfolio companies

March 6, 2026

Labiotech Beyond Biotech podcast with Sean A. MacDonald, CEO of Kainova Therapeutics – Reversing tumor immunosuppression with next-gen GPCR modulation

March 6, 2026

Labiotech Beyond Biotech podcast with Sean A. MacDonald, CEO of Kainova Therapeutics – Reversing tumor immunosuppression with next-gen GPCR modulation

March 3, 2026

HiRO Leads Cross‑Border Dialogue at JPM, Offering Insights for Biotechs Seeking Asian Investment

SOMERSET, N.J., March 3, 2026 -- Harvest Integrated Research Organization (HiRO), a global contract research…

March 3, 2026

HiRO Leads Cross‑Border Dialogue at JPM, Offering Insights for Biotechs Seeking Asian Investment

SOMERSET, N.J., March 3, 2026 -- Harvest Integrated Research Organization (HiRO), a global contract research…

March 2, 2026

Interview with Peter Pang: Where Biosimilar CMC Risk Really Sits Today

March 2, 2026

Interview with Peter Pang: Where Biosimilar CMC Risk Really Sits Today

February 26, 2026

Podcast featuring Jean-Marie Cuillerot, Chief Medical Officer at Kainova Therapeutics – Closing the gap on rare diseases in 2026

February 26, 2026

Podcast featuring Jean-Marie Cuillerot, Chief Medical Officer at Kainova Therapeutics – Closing the gap on rare diseases in 2026

February 26, 2026

Evox Therapeutics Partners with Rett Syndrome Research Trust to Evaluate ExoEdit® Technology to Enable Gene Editing in Rett Syndrome

February 26, 2026

Evox Therapeutics Partners with Rett Syndrome Research Trust to Evaluate ExoEdit® Technology to Enable Gene Editing in Rett Syndrome